Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
9-valent CRM197-Conjugated Pneumococcal Vaccine in Elderly Adults
NCT00133549Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2000
- Primary completion
- Dec 2002
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of nine-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2000; status: completed.
02
Drugs
nine-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00133549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133549.